GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » Goodwill-to-Asset

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Goodwill-to-Asset : 0.00 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Jiangsu Jibeier Pharmaceutical Co's Goodwill for the quarter that ended in Mar. 2024 was ¥0.0 Mil. Jiangsu Jibeier Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥2,213.1 Mil. Therefore, Jiangsu Jibeier Pharmaceutical Co's Goodwill to Asset Ratio for the quarter that ended in Mar. 2024 was 0.00.


Jiangsu Jibeier Pharmaceutical Co Goodwill-to-Asset Historical Data

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Jibeier Pharmaceutical Co Goodwill-to-Asset Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Goodwill-to-Asset
Get a 7-Day Free Trial - - - - -

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Jiangsu Jibeier Pharmaceutical Co's Goodwill-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Jibeier Pharmaceutical Co's Goodwill-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's Goodwill-to-Asset falls into.



Jiangsu Jibeier Pharmaceutical Co Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Jiangsu Jibeier Pharmaceutical Co's Goodwill to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Goodwill to Asset (A: Dec. 2023 )=Goodwill/Total Assets
=0/2209.668
=0.00

Jiangsu Jibeier Pharmaceutical Co's Goodwill to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Goodwill to Asset (Q: Mar. 2024 )=Goodwill/Total Assets
=0/2213.112
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Jibeier Pharmaceutical Co  (SHSE:688566) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Jiangsu Jibeier Pharmaceutical Co Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Business Description

Traded in Other Exchanges
N/A
Address
High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Executives
Wu Ying senior management
Zhang Chun Director
Zhao Suo Fu senior management
Li Hai Dao Core technical personnel
Di Jian Zhong senior management
Qin Xu Feng Core technical personnel
Wu Xiu Gen Core technical personnel
Yu Xin Jun Directors, senior managers
Hu Tao Director

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Headlines

No Headlines